Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities
2015 ◽
Vol 58
(22)
◽
pp. 8952-8969
◽
2015 ◽
Vol 6
(8)
◽
pp. 1428-1435
◽
2020 ◽
Vol 63
(4)
◽
pp. 1671-1683
◽
Keyword(s):
2013 ◽
Vol 56
(5)
◽
pp. 2139-2149
◽
2016 ◽
Vol 59
(10)
◽
pp. 4985-4998
◽
2020 ◽
Vol 63
(14)
◽
pp. 7663-7694
◽
2004 ◽
Vol 127
(2)
◽
pp. 497-503
◽
2019 ◽
Vol 62
(8)
◽
pp. 4142-4157
◽
Keyword(s):
2003 ◽
Vol 23
(12)
◽
pp. 4888-4898
◽
Keyword(s):